On August 5, 2020 RGENIX, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics, reported that it has been selected to present at multiple virtual healthcare investor conferences taking place during the month of August (Press release, Rgenix, AUG 5, 2020, View Source [SID1234562893]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

These conferences include:

LifeSci Partners Summer Symposium
August 5, 2020 at 11:30 A.M EDT

BTIG Virtual Biotechnology Conference 2020
August 11, 2020 at 3:30 P.M. EDT

2020 Wedbush PacGrow Healthcare Conference
August 12, 2020 at 9:10 A.M. EDT

Canaccord Genuity 40th Annual Growth Conference
August 13, 2020 at 8:00 A.M. EDT

Links to the live and archived versions of these presentations are available on Rgenix’s website within the News section.